Burning Rock Biotech Limited reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 125.62 million compared to CNY 142.52 million a year ago. Net loss was CNY 121.55 million compared to CNY 185.25 million a year ago.

Basic loss per share from continuing operations was CNY 11.9 compared to CNY 18.1 a year ago. Diluted loss per share from continuing operations was CNY 11.9 compared to CNY 18.1 a year ago.